Table 1. QRDR mutation genotypes and fluoroquinolone MICs and MPCs for Pm field strains.
Mutation type | Number of strains | MIC range (µg/ml) | Substitution in | MPC range a) (µg/ml)/ MSW b) | |||||
---|---|---|---|---|---|---|---|---|---|
CIP | ENR | ORB | gyrA | parC | CIP | ENR | ORB | ||
Wild | 9 | 0.03–0.25 | 0.03–0.25 | 0.03–0.06 | None | None | 0.125–0.5 / 0.06–0.25 | 0.125–0.5 / 0.06–0.25 | 0.125–0.5 / 0.06–1.9 |
I | 13 | 0.5 | 0.5 | 0.25–0.5 | Asp87 to Asn | None | 4–16 / 3.5–15.5 | 8–32 / 3.5–31.5 | 4–32 / 3.5–31.5 |
II | 1 | 0.5 | 0.5 | 0.5 | Ala84 to Pro | None | 4/ 3.5 | 16/ 15.5 | 32/ 31.5 |
a) MPCs, mutant prevention concentrations were determined on Mueller-Hinton plates for ciprofloxacin (CIP), enrofloxacin (ENR) and orbifloxacin (ORB). b) MSW, mutant selection window (antibiotic concentration found between the minimum inhibitory concentration and MPC).